The role of tunneling nanotubes during early stages of HIV infection and reactivation: implications in HIV cure

Abstract Tunneling nanotubes (TNTs), also called cytonemes or tumor microtubes, correspond to cellular processes that enable long-range communication. TNTs are plasma membrane extensions that form tubular processes that connect the cytoplasm of two or more cells. TNTs are mostly expressed during the early stages of development and poorly expressed in adulthood. However, in disease conditions such as stroke, cancer, and viral infections such as HIV, TNTs proliferate, but their role is poorly understood. TNTs function has been associated with signaling coordination, organelle sharing, and the transfer of infectious agents such as HIV. Here, we describe the critical role and function of TNTs during HIV infection and reactivation, as well as the use of TNTs for cure strategies.

[1]  W. Balduini,et al.  Melatonin, tunneling nanotubes, mesenchymal cells, and tissue regeneration , 2022, Neural regeneration research.

[2]  M. Donoso,et al.  Identification, Quantification, and Characterization of HIV-1 Reservoirs in the Human Brain , 2022, Cells.

[3]  T. Kuner,et al.  Glioblastoma hijacks neuronal mechanisms for brain invasion , 2022, Cell.

[4]  C. Kepley,et al.  Identification and Characterization of Tunneling Nanotubes Involved in Human Mast Cell FcεRI-Mediated Apoptosis of Cancer Cells , 2022, Cancers.

[5]  V. Uversky,et al.  SARS-CoV-2: A Master of Immune Evasion , 2022, Biomedicines.

[6]  E. Eugenin,et al.  Direct Cell-Cell Communication via Membrane Pores, Gap Junction Channels, and Tunneling Nanotubes: Medical Relevance of Mitochondrial Exchange , 2022, International journal of molecular sciences.

[7]  L. Sardo,et al.  Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies , 2022, Frontiers in Microbiology.

[8]  Sung Hyun Lee,et al.  Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy , 2022, Frontiers in Oncology.

[9]  A. Seguro,et al.  Tenofovir-induced renal and bone toxicity: report of two cases and literature review , 2022, Revista do Instituto de Medicina Tropical de Sao Paulo.

[10]  W. Wang,et al.  Intercellular transfer of mitochondria via tunneling nanotubes protects against cobalt nanoparticle-induced neurotoxicity and mitochondrial damage , 2021, Nanotoxicology.

[11]  Ranjeet Kumar,et al.  An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy , 2021, Scientific Reports.

[12]  J. Garcia,et al.  Tunneling nanotube formation promotes survival against 5‐fluorouracil in MCF‐7 breast cancer cells , 2021, FEBS open bio.

[13]  M. Levin,et al.  Beyond Neurons: Long Distance Communication in Development and Cancer , 2021, Frontiers in Cell and Developmental Biology.

[14]  C. Scagnolari,et al.  An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19 , 2021, Drug Delivery and Translational Research.

[15]  E. Eugenin,et al.  HIV infection of astrocytes compromises inter-organelle interactions and inositol phosphate metabolism: A potential mechanism of bystander damage and viral reservoir survival , 2021, Progress in Neurobiology.

[16]  S. Nath,et al.  Amyloid-β induced membrane damage instigates tunneling nanotube-like conduits by p21-activated kinase dependent actin remodulation. , 2021, Biochimica et biophysica acta. Molecular basis of disease.

[17]  K. Bhat,et al.  Tunneling nanotubes, TNT, communicate glioblastoma with surrounding non-tumor astrocytes to adapt them to hypoxic and metabolic tumor conditions , 2021, Scientific Reports.

[18]  S. N. Witt,et al.  Trojan horses and tunneling nanotubes enable α-synuclein pathology to spread in Parkinson disease , 2021, PLoS biology.

[19]  D. Shukla,et al.  Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer , 2021, Frontiers in Immunology.

[20]  Qiong Zhou,et al.  The Functions, Methods, and Mobility of Mitochondrial Transfer Between Cells , 2021, Frontiers in Oncology.

[21]  C. Van Lint,et al.  Shocking HIV-1 with immunomodulatory latency reversing agents. , 2021, Seminars in immunology.

[22]  S. Swindells,et al.  The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data? , 2021, Journal of the International Association of Providers of AIDS Care.

[23]  B. Malissen,et al.  Regulation of Inflammatory Response by Transmembrane Adaptor Protein LST1 , 2021, Frontiers in Immunology.

[24]  C. Zurzolo Tunneling nanotubes: Reshaping connectivity. , 2021, Current opinion in cell biology.

[25]  C. Marzolini,et al.  Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine , 2021, Clinical Pharmacokinetics.

[26]  E. Eugenin,et al.  Astrocytes are HIV reservoirs in the brain: A cell type with poor HIV infectivity and replication but efficient cell‐to‐cell viral transfer , 2021, Journal of neurochemistry.

[27]  J. Moorman,et al.  HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies , 2021, Cells.

[28]  Anice C. Lowen,et al.  Rab11a mediates cell-cell spread and reassortment of influenza A virus genomes via tunneling nanotubes , 2021, bioRxiv.

[29]  E. Haddad,et al.  HIV-1 cure strategies: why CRISPR? , 2020, Expert opinion on biological therapy.

[30]  M. Donoso,et al.  Role of Tunneling Nanotube–like Structures during the Early Events of HIV Infection: Novel Features of Tissue Compartmentalization and Mechanism of HIV Spread , 2020, The Journal of Immunology.

[31]  Zhipeng Qiu,et al.  Modeling HIV multiple infection. , 2020, Journal of theoretical biology.

[32]  D. Wodarz,et al.  Quantifying the dynamics of viral recombination during free virus and cell-to-cell transmission in HIV-1 infection , 2020, bioRxiv.

[33]  M. Kazanietz,et al.  Rho GTPases and the emerging role of tunneling nanotubes in physiology and disease. , 2020, American journal of physiology. Cell physiology.

[34]  K. Bhat,et al.  Tunneling Nanotubes Mediate Adaptation of Glioblastoma Cells to Temozolomide and Ionizing Radiation Treatment , 2020, iScience.

[35]  D. Langford,et al.  Inter and Intracellular mitochondrial trafficking in health and disease , 2020, Ageing Research Reviews.

[36]  H. Nasser,et al.  M-Sec facilitates intercellular transmission of HIV-1 through multiple mechanisms , 2020, Retrovirology.

[37]  Zhipeng Qiu,et al.  Modeling the role of macrophages in HIV persistence during antiretroviral therapy , 2020, Journal of mathematical biology.

[38]  E. Eugenin,et al.  HIV infects astrocytes in vivo and egresses from the brain to the periphery , 2020, PLoS pathogens.

[39]  B. Julg,et al.  Therapeutic Vaccines for the Treatment of HIV. , 2020, Translational research : the journal of laboratory and clinical medicine.

[40]  K. Katagiri,et al.  HIV Reactivation in Latently Infected Cells with Virological Synapse-Like Cell Contact , 2020, Viruses.

[41]  Mirko H. H. Schmidt,et al.  Tunneling Nanotubes and Tumor Microtubes in Cancer , 2020, Cancers.

[42]  T. Murakami,et al.  Virion-incorporated PSGL-1 and CD43 inhibit both cell-free infection and transinfection of HIV-1 by preventing virus–cell binding , 2020, Proceedings of the National Academy of Sciences.

[43]  M. Szeliga,et al.  Targeting Glutamine Addiction in Gliomas , 2020, Cancers.

[44]  Z. Debyser,et al.  Block-And-Lock Strategies to Cure HIV Infection , 2020, Viruses.

[45]  C. Van Lint,et al.  Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs , 2020, Frontiers in Microbiology.

[46]  Eliseo A. Eugenin,et al.  Role of cell‐to‐cell communication in cancer: New features, insights, and directions , 2019, Cancer reports.

[47]  G. Pilkington,et al.  Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons , 2019, International journal of molecular sciences.

[48]  A. Bosque,et al.  HIV-1 Latency and Latency Reversal: Does Subtype Matter? , 2019, Viruses.

[49]  R. Ruprecht,et al.  Mucosal Antibodies: Defending Epithelial Barriers against HIV-1 Invasion , 2019, Vaccines.

[50]  S. Venneti,et al.  Glutamine Metabolism in Brain Tumors , 2019, Cancers.

[51]  C. Van Lint,et al.  Microglial Cells: The Main HIV-1 Reservoir in the Brain , 2019, Front. Cell. Infect. Microbiol..

[52]  S. Cherqui,et al.  Macrophage polarization impacts tunneling nanotube formation and intercellular organelle trafficking , 2019, Scientific Reports.

[53]  M. Clerici,et al.  Phylogenies in ART: HIV reservoirs, HIV latency and drug resistance. , 2019, Current opinion in pharmacology.

[54]  M. Tolstrup,et al.  Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues , 2019, Front. Microbiol..

[55]  Xia Wang,et al.  HIV low viral load persistence under treatment: Insights from a model of cell-to-cell viral transmission , 2019, Appl. Math. Lett..

[56]  H. Gendelman,et al.  Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice , 2019, Nature Communications.

[57]  L. Agosto,et al.  Mechanisms of HIV-1 cell-to-cell transmission and the establishment of the latent reservoir. , 2019, Virus research.

[58]  E. Masliah,et al.  HIV and Alzheimer’s disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein , 2019, Journal of NeuroVirology.

[59]  E. Eugenin,et al.  HIV infection and latency induce a unique metabolic signature in human macrophages , 2019, Scientific Reports.

[60]  M. Kuroda,et al.  Tuberculosis Exacerbates HIV-1 Infection through IL-10/STAT3-Dependent Tunneling Nanotube Formation in Macrophages. , 2019, Cell reports.

[61]  Yong-feng Yang,et al.  Myosin-X Silencing in the Trabecular Meshwork Suggests a Role for Tunneling Nanotubes in Outflow Regulation , 2019, Investigative ophthalmology & visual science.

[62]  C. Flexner,et al.  Long-Acting HIV Drugs for Treatment and Prevention. , 2019, Annual review of medicine.

[63]  K. Gousset,et al.  Correlative cryo-electron microscopy reveals the structure of TNTs in neuronal cells , 2019, Nature Communications.

[64]  S. Izadmehr,et al.  Sequential trafficking of Env and Gag to HIV-1 T cell virological synapses revealed by live imaging , 2019, Retrovirology.

[65]  E. Freed,et al.  Myosin-X is essential to the intercellular spread of HIV-1 Nef through tunneling nanotubes , 2018, Journal of Cell Communication and Signaling.

[66]  M. Naghavi "APP"reciating the complexity of HIV-induced neurodegenerative diseases , 2018, PLoS pathogens.

[67]  S. Iwami,et al.  Dynamics of HIV-1 coinfection in different susceptible target cell populations during cell-free infection. , 2018, Journal of theoretical biology.

[68]  V. Piguet,et al.  Masters of manipulation: Viral modulation of the immunological synapse , 2018, Cellular microbiology.

[69]  Donald W. Harms,et al.  Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection , 2018, BMC Immunology.

[70]  Subbaya Subramanian,et al.  Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic Cancer , 2018, Scientific Reports.

[71]  M. Bomsel,et al.  Live Imaging of HIV-1 Transfer across T Cell Virological Synapse to Epithelial Cells that Promotes Stromal Macrophage Infection. , 2018, Cell reports.

[72]  E. Eugenin,et al.  The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis , 2018, International journal of molecular sciences.

[73]  S. Benichou,et al.  Mechanisms for Cell-to-Cell Transmission of HIV-1 , 2018, Front. Immunol..

[74]  G. Lugo-Villarino,et al.  Tunneling Nanotubes: Intimate Communication between Myeloid Cells , 2018, Front. Immunol..

[75]  E. Martegani,et al.  RalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells , 2018, Experimental cell research.

[76]  S. Lewin,et al.  Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV. , 2018, Cell host & microbe.

[77]  E. Eugenin,et al.  Tunneling nanotubes (TNT) mediate long-range gap junctional communication: Implications for HIV cell to cell spread , 2017, Scientific Reports.

[78]  Teresa M. Ribeiro-Rodrigues,et al.  Role of connexin 43 in different forms of intercellular communication – gap junctions, extracellular vesicles and tunnelling nanotubes , 2017, Journal of Cell Science.

[79]  E. Boritz,et al.  Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants. , 2017, Cell reports.

[80]  M. D. Den Boer,et al.  Tunneling Nanotubes and Gap Junctions–Their Role in Long-Range Intercellular Communication during Development, Health, and Disease Conditions , 2017, Front. Mol. Neurosci..

[81]  E. Eugenin,et al.  HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim , 2017, Scientific Reports.

[82]  K. Manova-Todorova,et al.  Imaging Tunneling Membrane Tubes Elucidates Cell Communication in Tumors. , 2017, Trends in cancer.

[83]  Beth S. Lee,et al.  Regulation of Osteoclast Differentiation by Myosin X , 2017, Scientific Reports.

[84]  Y. Iwasa,et al.  Number of infection events per cell during HIV-1 cell-free infection , 2017, Scientific Reports.

[85]  K. Sahu,et al.  Macrophage conditioned medium induced cellular network formation in MCF‐7 cells through enhanced tunneling nanotube formation and tunneling nanotube mediated release of viable cytoplasmic fragments , 2017, Experimental Cell Research.

[86]  C. Jorgensen,et al.  Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy , 2017, Stem cells international.

[87]  M. Tremblay,et al.  HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood–Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration , 2017, The Journal of Immunology.

[88]  E. Boyden,et al.  Influenza virus exploits tunneling nanotubes for cell-to-cell spread , 2017, Scientific Reports.

[89]  V. Thayanithy,et al.  Tunneling nanotubes: an alternate route for propagation of the bystander effect following oncolytic viral infection , 2016, Molecular therapy oncolytics.

[90]  M. Colin,et al.  Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies , 2016, Acta neuropathologica communications.

[91]  I. Parker,et al.  Communication of Ca(2+) signals via tunneling membrane nanotubes is mediated by transmission of inositol trisphosphate through gap junctions. , 2016, Cell calcium.

[92]  R. Dewar,et al.  Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy , 2016, Proceedings of the National Academy of Sciences.

[93]  R. Siliciano,et al.  Defective proviruses rapidly accumulate during acute HIV-1 infection , 2016, Nature Medicine.

[94]  Hongzhou Lu,et al.  The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb , 2016, Scientific Reports.

[95]  Andrea K. Thoma-Kress,et al.  Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission , 2016, Viruses.

[96]  H. Nasser,et al.  Potential Role of the Formation of Tunneling Nanotubes in HIV-1 Spread in Macrophages , 2016, The Journal of Immunology.

[97]  R. Siliciano,et al.  HIV reservoirs: what, where and how to target them , 2015, Nature Reviews Microbiology.

[98]  O. Garaschuk,et al.  Brain tumour cells interconnect to a functional and resistant network , 2015, Nature.

[99]  M. D. Den Boer,et al.  B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment. , 2015, Blood.

[100]  H. Vaudry,et al.  Structural and functional analysis of tunneling nanotubes (TnTs) using gCW STED and gconfocal approaches , 2015, Biology of the cell.

[101]  Y. Iwasa,et al.  Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin , 2015, Scientific Reports.

[102]  S. Curley,et al.  Radiofrequency treatment alters cancer cell phenotype , 2015, Scientific Reports.

[103]  A. Zumbusch,et al.  Lipid droplets as a novel cargo of tunnelling nanotubes in endothelial cells , 2015, Scientific Reports.

[104]  R. Swanstrom,et al.  Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS , 2015, Current HIV/AIDS Reports.

[105]  H. Gerdes,et al.  Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells , 2015, Cell Death and Differentiation.

[106]  S. Buchbinder,et al.  HIV infection , 2015, Nature Reviews Disease Primers.

[107]  J. Kappes,et al.  Macrophage Infection via Selective Capture of HIV-1-Infected CD4+ T Cells , 2014, Cell host & microbe.

[108]  R. Siliciano,et al.  A primary CD4+ T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence , 2014, Nature Protocols.

[109]  Benjamin K. Chen,et al.  Unique Features of HIV-1 Spread through T Cell Virological Synapses , 2014, PLoS pathogens.

[110]  V. Thayanithy,et al.  Tumor-stromal cross talk: direct cell-to-cell transfer of oncogenic microRNAs via tunneling nanotubes. , 2014, Translational research : the journal of laboratory and clinical medicine.

[111]  D. Margolis,et al.  Eradicating HIV-1 infection: seeking to clear a persistent pathogen , 2014, Nature Reviews Microbiology.

[112]  A. Pau,et al.  Antiretroviral therapy: current drugs. , 2014, Infectious disease clinics of North America.

[113]  V. Ferreira,et al.  Influence of Common Mucosal Co‐Factors on HIV Infection in the Female Genital Tract , 2014, American journal of reproductive immunology.

[114]  M. Gerstein,et al.  Cellular Superspreaders: An Epidemiological Perspective on HIV Infection inside the Body , 2014, PLoS pathogens.

[115]  L. Margolis,et al.  HIV‐1 Vaginal Transmission: Cell‐Free or Cell‐Associated Virus? , 2014, American journal of reproductive immunology.

[116]  K. Manova-Todorova,et al.  Tumor exosomes induce tunneling nanotubes in lipid raft-enriched regions of human mesothelioma cells. , 2014, Experimental cell research.

[117]  D. Bettenworth,et al.  Regulated expression of leukocyte-specific transcript (LST) 1 in human intestinal inflammation , 2014, Inflammation Research.

[118]  A. Mak p53 in cell invasion, podosomes, and invadopodia , 2014, Cell adhesion & migration.

[119]  Gerdes,et al.  Tunneling nanotubes Diversity in morphology and structure , 2014 .

[120]  J. Berman,et al.  Cytochrome c dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium‐dependent mechanism , 2013, Journal of neurochemistry.

[121]  W. Greene,et al.  Calcium/Calcineurin Synergizes with Prostratin to Promote NF-κB Dependent Activation of Latent HIV , 2013, PloS one.

[122]  L. Marzo,et al.  Myo10 is a key regulator of TNT formation in neuronal cells , 2013, Journal of Cell Science.

[123]  R. Siliciano,et al.  Targeting HIV latency: pharmacologic strategies toward eradication. , 2013, Drug discovery today.

[124]  K. Koyano,et al.  Tunneling nanotube formation is essential for the regulation of osteoclastogenesis , 2013, Journal of cellular biochemistry.

[125]  E. Verdin,et al.  Reactivation of latent HIV by histone deacetylase inhibitors. , 2013, Trends in microbiology.

[126]  H. Gerdes,et al.  Tunneling nanotubes, an emerging intercellular communication route in development , 2013, Mechanisms of Development.

[127]  E. Kremmer,et al.  LST1 promotes the assembly of a molecular machinery responsible for tunneling nanotube formation , 2013, Journal of Cell Science.

[128]  P. Uchil,et al.  Cell-to-Cell Transmission Can Overcome Multiple Donor and Target Cell Barriers Imposed on Cell-Free HIV , 2013, PloS one.

[129]  M. Toborek,et al.  Infection of human pericytes by HIV-1 disrupts the integrity of the blood–brain barrier , 2012, Journal of cellular and molecular medicine.

[130]  R. Siliciano,et al.  Redefining the viral reservoirs that prevent HIV-1 eradication. , 2012, Immunity.

[131]  Hans-Hermann Gerdes,et al.  Long-distance electrical coupling via tunneling nanotubes. , 2012, Biochimica et biophysica acta.

[132]  S. Deeks HIV: Shock and kill , 2012, Nature.

[133]  K. Manova-Todorova,et al.  Tunneling Nanotubes , 2012, Communicative & integrative biology.

[134]  K. Manova-Todorova,et al.  Tunneling Nanotubes Provide a Unique Conduit for Intercellular Transfer of Cellular Contents in Human Malignant Pleural Mesothelioma , 2012, PloS one.

[135]  Ju Han Kim,et al.  Mesenchymal Stem Cells Transfer Mitochondria to the Cells with Virtually No Mitochondrial Function but Not with Pathogenic mtDNA Mutations , 2012, PloS one.

[136]  P. Sharp,et al.  Origins of HIV and the AIDS pandemic. , 2011, Cold Spring Harbor perspectives in medicine.

[137]  Ron Milo,et al.  Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy , 2011, Nature.

[138]  Davey M. Smith,et al.  Tissue-specific HIV-1 infection: why it matters. , 2011, Future virology.

[139]  Y. Wang,et al.  Tunneling-nanotube development in astrocytes depends on p53 activation , 2011, Cell Death and Differentiation.

[140]  K. Williamson,et al.  Malaria parasites form filamentous cell-to-cell connections during reproduction in the mosquito midgut , 2011, Cell Research.

[141]  Susan Moir,et al.  Pathogenic mechanisms of HIV disease. , 2011, Annual review of pathology.

[142]  R. Siliciano,et al.  HIV latency. , 2011, Cold Spring Harbor perspectives in medicine.

[143]  Kevin C. Olivieri,et al.  Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation , 2012, Retrovirology.

[144]  Nickolay V. Bukoreshtliev,et al.  Animal cells connected by nanotubes can be electrically coupled through interposed gap-junction channels , 2010, Proceedings of the National Academy of Sciences.

[145]  Alan S. Perelson,et al.  Current Estimates for HIV-1 Production Imply Rapid Viral Clearance in Lymphoid Tissues , 2010, PLoS Comput. Biol..

[146]  O. Schwartz,et al.  HIV-1 Virological Synapse: Live Imaging of Transmission , 2010, Viruses.

[147]  Q. Sattentau,et al.  Cell-to-Cell Spread of Retroviruses , 2010, Viruses.

[148]  Marie-Claude Boily,et al.  HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention , 2010, International journal of epidemiology.

[149]  S. Kimura,et al.  M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex , 2009, Nature Cell Biology.

[150]  J. Javitch,et al.  Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. , 2009, The American journal of pathology.

[151]  E. Hodneland,et al.  Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells , 2009, FEBS letters.

[152]  J. Berman,et al.  Tunneling nanotubes (TNT) , 2009 .

[153]  Alberto Bosque,et al.  Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. , 2009, Blood.

[154]  J. Berman,et al.  Tunneling nanotubes (TNT) are induced by HIV-infection of macrophages: a potential mechanism for intercellular HIV trafficking. , 2009, Cellular immunology.

[155]  E. Hodneland,et al.  Tunneling nanotube (TNT)-like structures facilitate a constitutive, actomyosin-dependent exchange of endocytic organelles between normal rat kidney cells. , 2008, Experimental cell research.

[156]  Nathan M Sherer,et al.  Cytonemes and tunneling nanotubules in cell-cell communication and viral pathogenesis. , 2008, Trends in cell biology.

[157]  N. B. Viana,et al.  Structure and elastic properties of tunneling nanotubes , 2008, European Biophysics Journal.

[158]  H. Gerdes,et al.  Tunneling nanotubes: A new route for the exchange of components between animal cells , 2007, FEBS letters.

[159]  M. Neil,et al.  Structurally Distinct Membrane Nanotubes between Human Macrophages Support Long-Distance Vesicular Traffic or Surfing of Bacteria1 , 2006, The Journal of Immunology.

[160]  V. KewalRamani,et al.  Dendritic-cell interactions with HIV: infection and viral dissemination , 2006, Nature Reviews Immunology.

[161]  Erlend Hodneland,et al.  Automated detection of tunneling nanotubes in 3D images , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[162]  T. Kornberg,et al.  Dependence of Drosophila wing imaginal disc cytonemes on Decapentaplegic , 2005, Nature.

[163]  Xiaoling Zhang,et al.  Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes , 2005, Journal of Cell Science.

[164]  Alan S Perelson,et al.  HIV dynamics with multiple infections of target cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[165]  Hidde L Ploegh,et al.  CX3CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance , 2005, Science.

[166]  J. Berg,et al.  A microtubule-binding myosin required for nuclear anchoring and spindle assembly , 2004, Nature.

[167]  D. Davis,et al.  Cutting Edge: Membrane Nanotubes Connect Immune Cells12 , 2004, The Journal of Immunology.

[168]  R. Pomerantz,et al.  HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[169]  J. Alcamí,et al.  Prostratin Induces HIV Activation and Downregulates HIV Receptors in Peripheral Blood Lymphocytes , 2004, Antiviral therapy.

[170]  Qingsheng Li,et al.  Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[171]  Hans-Hermann Gerdes,et al.  Nanotubular Highways for Intercellular Organelle Transport , 2004, Science.

[172]  Jianbo Chen,et al.  Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[173]  D. Ho,et al.  HIV-1 dynamics in vivo: implications for therapy , 2003, Nature Reviews Microbiology.

[174]  J. Zack,et al.  Identification of T cell-signaling pathways that stimulate latent HIV in primary cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[175]  John P. Moore,et al.  Inhibiting sexual transmission of HIV-1 infection , 2003, Nature Reviews Microbiology.

[176]  J. Berman,et al.  TNF-α Plus IFN-γ Induce Connexin43 Expression and Formation of Gap Junctions Between Human Monocytes/Macrophages That Enhance Physiological Responses 1 , 2003, The Journal of Immunology.

[177]  G. Bocharov,et al.  Recombination: Multiply infected spleen cells in HIV patients , 2002, Nature.

[178]  P. Ricciardi-Castagnoli,et al.  Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria , 2001, Nature Immunology.

[179]  Peng Li,et al.  Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. , 1999, Virology.

[180]  D. Richman,et al.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.

[181]  V. Mermall,et al.  Unconventional myosins in cell movement, membrane traffic, and signal transduction. , 1998, Science.

[182]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[183]  Alan S. Perelson,et al.  Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.

[184]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[185]  Robert F. Siliciano,et al.  In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency , 1995, Nature Medicine.

[186]  R Blumenthal,et al.  Quantitation of human immunodeficiency virus type 1 infection kinetics , 1993, Journal of virology.

[187]  R. Strumpf,et al.  ACS RX flow support catheter as a temporary stent for dissection or occlusion during balloon angioplasty: initial experience. , 1992, Catheterization and cardiovascular diagnosis.

[188]  K Inaba,et al.  Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. , 1992, Science.

[189]  C. Rinaldo,et al.  Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody , 1989, Journal of virology.